Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Pilgrim agree with that. Integumen is a growth company so sit back and look at the Fundamentals getting stronger.
Have just under 58k myself which iv sat on for over a year now. Only think that has changed is the Fundamentals for the better. Gla
Yes Trils . GB is determined to build and develop these partnerships that are being put in place and realise some proper value in Integumen. He’s not interested in daily sp movement.. he knows that Rome wasn’t built in a day but is extremely confident the team are onto something special here. My personal time scales are 3-5 years here. Currently got £50k in which is nothing to some, a lot for others, but will be adding more in the next month.. hopefully still be sub 2. In excess of £4M T/O this year to beat the target set and I think we’ll smash that.. £250-£500k my realistic aim..could well be more.. that’s the fun of the journey but there are plenty of progress markers to gauge against along the way
My target is 15p Odgie but if the end game is to sell the company I might consider sitting it out until then even if it means waiting several years.
I'd make no hasty decisions until the results in 6 weeks.
Knowledge will come from it, useable or not it's all necessary.
Hi Pilgrim, is that something GB has suggested in the past? I'm not doubting you just curious as something to consider regard an exit point.
GB won't let this go too early. He knows what it can be worth and wants to develop for another 3 years...a big CRO will take us out, but not cheaply I can assure you
Skin are obviously great at R&D. Love the fact projects that have long been forgotten about by investors become a reality and make an impact on the business. Ecowater is a perfect example of that. Lab on a chip will be the next reminder maybe? Shows they're not standing still and always looking to the future.
If it’s a take out, let’s hope there’s a bun fight first between a few cosmetic/pharma companies.
Well it’s nearly the weekend, might as well dream a bit.
Good luck all holders
Ditto Tatty. Frankly, a buy-out before the full value is realised is my biggest fear here! :-/
Good presentation. Ticks so many relevant boxes. Still a very modest MCAP at £21m. Would not be surprised if one of the big cosmetic or pharma cos attempted a buyout using some loose change.
Agreed. Thank you Mr Brandon. And thank you more generally for your continued responsiveness to us pesky shareholders. :-)
Best,
Mr T
Hi Gerry, Thanks for sharing the slide deck, really professional job done by someone there in putting that together.
Wow, future proofing or rather rapidly adapting processes to ensure growth can continue. One step ahead as per. No doubt the presentation will generate a lot of leads. Great we have access to a P3 lab, have started working with the virus and have experience with other pathogens.
I am not sure if shareholders grasped the implications of the slide on Virtual Clinical Trials 2021 and a solution for COVID19 restricted patients who must remain shielded in their home, Nursing Homes.
Effectively this enables skin disease clinical trials to be carried out with social distance rules by remotely capturing the Microbiome of a human volunteers' skin in their home under the supervision of a HD video remote supervisor, instantly freeze the swab, and ship to Labskin laboratories where the human volunteers' skin microbiome (surface) is cloned. The human volunteer/patient's cloned skin is then tested in Labskin laboratory, without the patient having to leave their home, if collected by a courier.
A fantastic presentation and all investors here should watch it. I can't pretend to understand everything but grasped the main concepts. The science involved is awesome and I bet the target audience had a lot to talk about. Some top class people starting to make some noise.
The Labskin team presented at the Microbiome Connect conference yesterday and details (including the ability to download the presentation slide deck - and detail notes) can be found here. https://www.labskin.co.uk/labskin-at-microbiome-connect-skin-2020/ Small additional information on the COVID-19 CL3 laboratory at the end of the Slide Deck that can be downloaded from this link